Mar 18, 2020   SOURCE: PR NewsWire

Global Cholesterol-Lowering Drugs Markets to 2027 - Includes Company Overviews, Financials, Recent Developments, and SWOT Analyses of Key Players

DUBLIN, March 18, 2020 /PRNewswire/ -- The "Cholesterol Lowering Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

This report on the global cholesterol lowering drugs market studies past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period from 2019 to 2027.

The report provides the overall market revenue of the cholesterol lowering drugs market for the period of 2017-2027, with 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the cholesterol lowering drugs market for the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involves bulk of research efforts, wherein, analysts carry out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involves referring to key players' product literature, annual reports, press releases, and relevant documents to understand the cholesterol lowering drugs market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approach to study various phenomena in the cholesterol lowering drugs market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the cholesterol lowering drugs market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the cholesterol lowering drugs market.

The report delves into the competitive landscape of the cholesterol lowering drugs market. Key players operating in the cholesterol lowering drugs market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOTs are some of the attributes of players in the cholesterol lowering drugs market that have been profiled in this report.

Key Questions Answered

    --  What is the sales/revenue generated by each drug class segment of the
        cholesterol lowering drugs market across all regions during the forecast
        period?
    --  What are the opportunities in the cholesterol lowering drugs market?
    --  What are the major drivers, restraints, opportunities, and threats in
        the market?
    --  Which region is likely to expand at the fastest CAGR during the forecast
        period?
    --  Which cholesterol lowering drugs class, indication, and distribution
        channel segments are expected to generate maximum revenue globally in
        2027? Which segment is projected to expand at the highest CAGR during
        the forecast period?
    --  What was the market share or position of different companies operating
        in the global market in 2018?

Research Objectives & Approach

The comprehensive report on the cholesterol lowering drugs market begins with an overview of the said market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study, pipeline analysis, key brand sales analysis, key merger & acquisition, and disease prevalence rate of different diseases and conditions.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into small sections. The entire report comprises an exhaustive collection of graphs and tables appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the cholesterol lowering drugs market, in terms of drug class, indication, distribution channel, and region. Key segments under each criteria have been studied at length, and the market share for each of them at the end of 2027 has been provided herein. Such valuable insights enable market stakeholders in making informed business decisions for investment in the cholesterol lowering drugs market.

Companies Mentioned

    --  Pfizer Inc.
    --  Sanofi
    --  GlaxoSmithKline plc
    --  Novartis AG
    --  Merck & Co. Inc.
    --  Amgen, Inc.
    --  Takeda Pharmaceutical Company Limited
    --  Sun Pharmaceutical Industries Ltd.
    --  AbbVie, Inc.
    --  Mylan N.V.

For more information about this report visit https://www.researchandmarkets.com/r/h8mxd1

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.


Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-cholesterol-lowering-drugs-markets-to-2027---includes-company-overviews-financials-recent-developments-and-swot-analyses-of-key-players-301026273.html

SOURCE Research and Markets